comprehensive -WSS

comprehensive

author：entertainment 2025-08-12 06:43:26 - browse：3

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Millions may soon lose Medicaid when they don't have to

WSS

Democrats decry new health bill for going easy on private equity

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Novo: Oral version of Ozempic leads to 15% weight loss

Millions may soon lose Medicaid when they don't have to

Patients, doctors are clashing about side effects of hormonal birth control

Millions may soon lose Medicaid when they don't have to

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

In age of alternative facts, a scholarly course on calling out crap

CDC Director Mandy Cohen on transparency, trust, and health

Dobbs anniversary: the lost opportunity of abortion as health care

Search called off for baby washed away in Pennsylvania flash flood

State Dept. review finds Biden bears some blame for Afghanistan failures

Millions may soon lose Medicaid when they don't have to

Medicare proposal to cover medical devices draws a mixed reaction

Patients, doctors are clashing about side effects of hormonal birth control

Anesthesiologist group: stop taking Ozempic before surgery

Senate panel puts off hardest PBM reforms for another day

focus

FDA approves first new drug developed for postpartum depression

Will the FTC rein in IQVIA's health data empire?

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

The battle over 'scope creep' and who gets to be called 'doctor'

The thinking behind the controversial eating disorder chatbot Tessa

Search called off for baby washed away in Pennsylvania flash flood

focus

explore

explore

focus